戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ently, allelic loss) occur in tumors in FAP (familial adenomatous polyposis).
2 ects had pathogenic variants associated with familial adenomatous polyposis.
3 sporadic tumors or in tumors associated with familial adenomatous polyposis.
4 the development of adenomas in subjects with familial adenomatous polyposis.
5 osis coli gene (APC) that is associated with familial adenomatous polyposis.
6 size 5 mm; range 1-13 mm) from patients with familial adenomatous polyposis.
7 fr) signaling on the Apc(Min) mouse model of familial adenomatous polyposis.
8 s in the treatment of ulcerative colitis and familial adenomatous polyposis.
9 on/activity in the Apc(Min/+) mouse model of familial adenomatous polyposis.
10 lastic role in the Apc(Min/+) mouse model of familial adenomatous polyposis.
11  (APC) allele can lead to the development of familial adenomatous polyposis.
12 rcinoma and causes regression of adenomas in familial adenomatous polyposis.
13 PAA), 1 had indeterminate colitis, and 8 had familial adenomatous polyposis.
14 mas, but do not have the florid phenotype of familial adenomatous polyposis.
15 bitor, on colorectal polyps in patients with familial adenomatous polyposis.
16 mber and size of adenomas in mouse models of familial adenomatous polyposis.
17 osses with ApcMin/+, a murine model of human familial adenomatous polyposis.
18 ired biopsies from IPAA patients with UC and familial adenomatous polyposis.
19 testinal tumor formation in a mouse model of familial adenomatous polyposis.
20 ous polyposis coli (APC) gene that underlies familial adenomatous polyposis.
21 urrence of colonic adenomas in patients with familial adenomatous polyposis.
22 the adenoma phenotype in this mouse model of familial adenomatous polyposis.
23 e number and size of polyps in patients with familial adenomatous polyposis.
24 ange, which are similar to those observed in familial adenomatous polyposis.
25 oli (APC) is associated with pathogenesis of familial adenomatous polyposis.
26 the leading causes of death in patients with familial adenomatous polyposis.
27 r interact with Apc, are important models of familial adenomatous polyposis.
28 al adenoma development in an animal model of familial adenomatous polyposis.
29 ally or in combination in an animal model of familial adenomatous polyposis.
30       Min mice provide a good model of human familial adenomatous polyposis.
31 Wnt pathway or APC gene mutations that cause familial adenomatous polyposis.
32  for the treatment of ulcerative colitis and familial adenomatous polyposis.
33 mphocyte depletion observed in this model of familial adenomatous polyposis.
34  that of patients with classic or attenuated familial adenomatous polyposis.
35 d several cancers such as retinoblastoma and familial adenomatous polyposis.
36   Diagnosis (chronic ulcerative colitis 97%, familial adenomatous polyposis 3%) and previous operativ
37 ugh studies of hereditary syndromes, such as familial adenomatous polyposis, a cancer predisposition
38 smaller median number of polyps than typical familial adenomatous polyposis, a wide variability in po
39 re also detected in APC(min) mouse and human familial adenomatous polyposis adenomas compared with no
40                                Patients with familial adenomatous polyposis after pouch surgery (n =
41 hers syndrome and the phenotypic features of familial adenomatous polyposis aid significantly in synd
42 r protein, germline mutation of which causes familial adenomatous polyposis, an autosomal intestinal
43            Using colectomy specimens from 16 familial adenomatous polyposis and 11 control cases, we
44                     Germline mutations cause familial adenomatous polyposis and at least two-thirds o
45 plications for dietary intervention in human familial adenomatous polyposis and colon cancer.
46 ajor syndromes related to colorectal cancer, familial adenomatous polyposis and hereditary non-polypo
47 al dominant hereditary forms of the disease, familial adenomatous polyposis and hereditary nonpolypos
48 ion of preexisting adenomas in patients with familial adenomatous polyposis and significantly inhibit
49  prevention of colon cancer in patients with familial adenomatous polyposis and sporadic polyps.
50 lasia type 2, von Hippel-Lindau disease, and familial adenomatous polyposis are examples of syndromes
51 The loss of APC function is observed in most familial adenomatous polyposis-associated and sporadic c
52                                              Familial adenomatous polyposis because of germline mutat
53  years) who were genotypically affected with familial adenomatous polyposis but phenotypically unaffe
54 y of 41 subjects genotypically affected with familial adenomatous polyposis but phenotypically unaffe
55  benefit not only in patients diagnosed with familial adenomatous polyposis but, perhaps, in other pr
56 ectomy is required for ulcerative colitis or familial adenomatous polyposis, but long-term data on fu
57 al polyp in animals and in patients with the familial adenomatous polyposis by downregulating beta-ca
58 zygote Min/+ mouse model, like patients with familial adenomatous polyposis, carries a nonsense mutat
59  the inherited autosomal dominant condition, familial adenomatous polyposis, celecoxib proved efficac
60 e associated with an attenuated phenotype of familial adenomatous polyposis coli (AAPC).
61 ly recognized as a potential complication of familial adenomatous polyposis coli (APC) and attenuated
62 and multiple colonic adenomas reminiscent of familial adenomatous polyposis coli (FAP).
63 rome of colon cancer predisposition known as familial adenomatous polyposis coli (FAP).
64 lastic phenotype similar to that observed in familial adenomatous polyposis coli in humans.
65 cancer, adenomas taken from individuals with familial adenomatous polyposis contain high levels of Ct
66     Colectomy specimens from 3 patients with familial adenomatous polyposis containing polypoid and n
67                                              Familial adenomatous polyposis (FAP) and attenuated FAP
68 ncer from human inherited syndromes, such as familial adenomatous polyposis (FAP) and hereditary non-
69                  Two well-defined syndromes, familial adenomatous polyposis (FAP) and hereditary non-
70 orders predisposing to colorectal cancer are familial adenomatous polyposis (FAP) and hereditary nonp
71 e patients who had undergone colectomies for familial adenomatous polyposis (FAP) and specimens from
72 rmines the type of the 'second hit', both in familial adenomatous polyposis (FAP) and sporadic colore
73 tween phenotypic expression in patients with familial adenomatous polyposis (FAP) and the site of mut
74 n the indications of MMVTx for patients with familial adenomatous polyposis (FAP) and the technical f
75                                Patients with familial adenomatous polyposis (FAP) are at markedly inc
76 denomatous polyposis coli (APC) mutations or familial adenomatous polyposis (FAP) are born with norma
77  clinicopathological scenarios: sporadic and familial adenomatous polyposis (FAP) associated.
78 attern dramatically altered for the worse in familial adenomatous polyposis (FAP) because these patie
79                     We studied patients with Familial Adenomatous Polyposis (FAP) because they are vi
80 riginally identified as a candidate gene for familial adenomatous polyposis (FAP) but further study i
81    These tumors often occur in patients with familial adenomatous polyposis (FAP) coli who have germ
82 were ulcerative colitis (UC) in 37 patients, familial adenomatous polyposis (FAP) in 12 patients, and
83 incidence of thyroid cancer in patients with Familial adenomatous polyposis (FAP) in a prospective st
84                                              Familial adenomatous polyposis (FAP) is a human cancer s
85                                              Familial adenomatous polyposis (FAP) is an autosomal dom
86                                              Familial adenomatous polyposis (FAP) is an autosomal-dom
87                                              Familial adenomatous polyposis (FAP) is caused by a domi
88                                              Familial Adenomatous Polyposis (FAP) is characterized by
89 the familial cancer predispositions known as familial adenomatous polyposis (FAP) or Gardner syndrome
90 tudied methylation in ACF from patients with familial adenomatous polyposis (FAP) or sporadic colorec
91 tations in colonic and duodenal tumours from familial adenomatous polyposis (FAP) patients has shown
92 of the earliest colonic tissue alteration in familial adenomatous polyposis (FAP) patients, we presen
93 multiple intestinal neoplasia (Min) mice and familial adenomatous polyposis (FAP) patients.
94 f adenomas after 4-6 months of treatment for familial adenomatous polyposis (FAP) patients.
95  commercial availability of gene testing for familial adenomatous polyposis (FAP) represents an impor
96 a pancreatoblastoma in an adult patient with familial adenomatous polyposis (FAP) suggests that they
97  mucosa from an XO/XY mosaic individual with familial adenomatous polyposis (FAP) was examined direct
98 tions in APC are classically associated with familial adenomatous polyposis (FAP), a highly penetrant
99 in, germline mutation of which characterizes familial adenomatous polyposis (FAP), an autosomal intes
100 in Adenomatous polyposis coli (APC) underlie familial adenomatous polyposis (FAP), an inherited cance
101 l ulcerative colitis, indeterminate colitis, familial adenomatous polyposis (FAP), and a select group
102 ssor gene APC are associated with hereditary familial adenomatous polyposis (FAP), and somatic mutati
103 tary nonpolyposis colorectal cancer (HNPCC), familial adenomatous polyposis (FAP), and sporadic CRC.
104                                              Familial adenomatous polyposis (FAP), due to germ-line m
105 arbor an inherited predisposition, including familial adenomatous polyposis (FAP), hereditary nonpoly
106 e frequently present in FGPs associated with familial adenomatous polyposis (FAP), raising the possib
107 m, combinatorial chemoprevention efficacy in familial adenomatous polyposis (FAP), signal of benefit
108 y (Family N) with symptoms characteristic of familial adenomatous polyposis (FAP), which is typically
109 way is a hallmark of many cancers, including familial adenomatous polyposis (FAP)-related desmoid tum
110  in APC(Min/+) mice, a murine model of human familial adenomatous polyposis (FAP).
111  most common gastric polyps in patients with familial adenomatous polyposis (FAP).
112 s coli (APC) tumor-suppressor gene result in familial adenomatous polyposis (FAP).
113 pment of intestinal adenomas associated with familial adenomatous polyposis (FAP).
114 al anastomosis (IPAA) done for patients with familial adenomatous polyposis (FAP).
115 but can occur in up to 21 % of patients with Familial Adenomatous Polyposis (FAP).
116 eoplasia type 2 (MEN2), Cowden syndrome, and familial adenomatous polyposis (FAP).
117 number of colorectal polyps in children with familial adenomatous polyposis (FAP).
118 e orthologous to those responsible for human familial adenomatous polyposis (FAP).
119 tion of colorectal adenomas in patients with familial adenomatous polyposis (FAP).
120 opic evaluation, especially in patients with familial adenomatous polyposis (FAP).
121  APC promoter 1B occur in rare families with familial adenomatous polyposis (FAP).
122 as well as DNA of individuals diagnosed with familial adenomatous polyposis (FAP).
123 strategy to iPSCs derived from patients with familial adenomatous polyposis (FAP-iPSCs) harboring ger
124  APC-mutation-negative probands with classic familial adenomatous polyposis (>100 adenomas).
125                        An attenuated form of familial adenomatous polyposis has been described, but t
126  history of polyp formation in patients with familial adenomatous polyposis has provided a benchmark
127 ereditary nonpolyposis colorectal cancer and familial adenomatous polyposis has provided insight into
128                                Patients with familial adenomatous polyposis have a nearly 100 percent
129 ition, clinical studies of the human disease familial adenomatous polyposis have demonstrated the eff
130 olyposis coli gene, which is responsible for familial adenomatous polyposis, have been described in p
131 ystic Fibrosis, Duchenne Muscular Dystrophy, Familial Adenomatous Polyposis, Hereditary Non-polyposis
132 romes such as multiple endocrine neoplasias, familial adenomatous polyposis, hereditary nonpolyposis
133                      These syndromes include familial adenomatous polyposis, hereditary nonpolyposis
134 r ulcerative colitis in 73% of the cases and familial adenomatous polyposis in 17%.
135 Celecoxib is prescribed for the treatment of familial adenomatous polyposis in humans, and the CEA-ba
136 amilial adenomatous polyposis mimics typical familial adenomatous polyposis in some cases but in othe
137     This investigation shows that attenuated familial adenomatous polyposis in the kindreds examined
138 ents with sporadic colorectal carcinomas and familial adenomatous polyposis, in 18 sporadic HPs from
139  colon adenomas recovered from patients with familial adenomatous polyposis, including adenomas as sm
140 ereditary nonpolyposis colorectal cancer and familial adenomatous polyposis, indicates that mutations
141                                              Familial adenomatous polyposis is an autosomal dominant
142                                              Familial adenomatous polyposis is an inherited genetic d
143                                              Familial adenomatous polyposis is caused by a germ-line
144 r tracks) and multiple POFLs associated with familial adenomatous polyposis is reviewed.
145 testing on 810 individuals from 2 attenuated familial adenomatous polyposis kindreds harboring an ide
146                  The phenotype of attenuated familial adenomatous polyposis mimics typical familial a
147 herited syndromes, including Lynch syndrome, familial adenomatous polyposis, MUTYH-associated polypos
148 ets in intestinal tissues from patients with familial adenomatous polyposis (n = 18) or sessile serra
149  adenomas (n = 18), adenomas associated with familial adenomatous polyposis (n = 7), hyperplastic pol
150                     Sex, age at diagnosis of familial adenomatous polyposis, number of polyps at firs
151 (the adenomatous polyposis coli gene) causes familial adenomatous polyposis of the colorectum.
152 d IPAA procedures for ulcerative colitis and familial adenomatous polyposis, of which all but 2 were
153     Patients who underwent genetic tests for familial adenomatous polyposis often received inadequate
154 lear-cut inherited Mendelian traits, such as familial adenomatous polyposis or hereditary nonpolyposi
155 uished clinically from cases with attenuated familial adenomatous polyposis or MUTYH-associated polyp
156 ested, 83.0 percent had clinical features of familial adenomatous polyposis or were at risk for the d
157               A diagnosis of Lynch syndrome, familial adenomatous polyposis, or another genetic syndr
158 ation of the premalignant crypt phenotype in familial adenomatous polyposis patients, the hypothesis
159                                              Familial adenomatous polyposis patients, who have a germ
160 e that closely simulates that found in human familial adenomatous polyposis patients.
161       Ectopic expression of APC, but not its familial adenomatous polyposis-related truncation mutant
162                             In patients with familial adenomatous polyposis, six months of twice-dail
163                          In murine models of familial adenomatous polyposis, specifically the multipl
164                 Studies of tumors from human familial adenomatous polyposis, sporadic colon cancer, a
165 rectal adenomas in animals and patients with familial adenomatous polyposis suggest that COX-2 inhibi
166 r at increased frequency among patients with familial adenomatous polyposis, suggesting that alterati
167                 In this study, using a human familial adenomatous polyposis syndrome susceptible mous
168 ilar to most mutations observed in the human familial adenomatous polyposis syndrome.
169 hereditary nonpolyposis colorectal cancer or familial adenomatous polyposis syndromes.
170  in the majority of the 30% of patients with familial adenomatous polyposis that do not test positive
171  genetic diseases, three females (1.6 %) had familial adenomatous polyposis; three patients (1 male a
172 th mutation-negative Lynch syndrome, 16 with familial adenomatous polyposis, two with constitutional
173  polyps from a 16-year-old male patient with familial adenomatous polyposis was insufflated, submerge
174 sis sulindac sulfide, which is used to treat familial adenomatous polyposis, was selected to detect g
175  for patients with indeterminate colitis and familial adenomatous polyposis were inconclusive because
176 intestinal neoplasia mice (a model for human familial adenomatous polyposis) were crossed with cyclin
177                                Patients with familial adenomatous polyposis who take NSAIDs, such as
178  patients with inflammatory bowel disease or familial adenomatous polyposis who underwent IAPT by a s

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top